BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22130933)

  • 1. Analysis of transcriptional regulation in bone cells.
    Jin H; Ralston SH
    Methods Mol Biol; 2012; 816():233-47. PubMed ID: 22130933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Transcriptional Regulation in Bone Cells.
    Jin H; Sophocleous A; Azfer A; Ralston SH
    Methods Mol Biol; 2019; 1914():145-167. PubMed ID: 30729464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of electrophoretic mobility shift assay and chromatin immunoprecipitation in the study of transcription in adipose cells.
    Musri MM; Gomis R; Parrizas M
    Methods Mol Biol; 2008; 456():231-47. PubMed ID: 18516565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of human fibroblast growth factor receptor 1 by E2F-1.
    Kanai M; Tashiro E; Maruki H; Minato Y; Imoto M
    Gene; 2009 Jun; 438(1-2):49-56. PubMed ID: 19303924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying transcriptional regulatory regions using reporter genes and DNA-protein interactions by chromatin immunoprecipitation.
    Ooi L; Wood IC
    Methods Mol Biol; 2008; 491():3-17. PubMed ID: 18998080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a functional CRE in the promoter of Fukuyama congenital muscular dystrophy gene fukutin.
    Fang H; Sodja C; Chartier J; Desbois A; Lei J; Walker PR; Sikorska M
    Brain Res Mol Brain Res; 2005 May; 136(1-2):1-11. PubMed ID: 15893581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of a polymorphism in the promoter region of the IL-12/23p40 gene.
    Shimokawa N; Nishiyama C; Hirota T; Tamari M; Hara M; Ikeda S; Okumura K; Ogawa H
    Clin Exp Allergy; 2009 Feb; 39(2):228-35. PubMed ID: 19134014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
    MÃ¥rtensson UE; Bristulf J; Owman C; Olde B
    Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the promoter of 1A6/DRIM, a novel cancer-related gene and identification of its transcriptional activator.
    Xing X; Du X; Lu Z; Ning T; Su X; Ke Y
    Gene; 2005 Jan; 344():161-9. PubMed ID: 15656982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
    Griffin BD; Moynagh PN
    Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
    Turner EC; Kinsella BT
    J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple promoters drive tissue-specific expression of the human M muscarinic acetylcholine receptor gene.
    Krejci A; Bruce AW; Dolezal V; Tucek S; Buckley NJ
    J Neurochem; 2004 Oct; 91(1):88-98. PubMed ID: 15379890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
    Stearns ME; Kim G; Garcia F; Wang M
    Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12.
    Sobue S; Hagiwara K; Banno Y; Tamiya-Koizumi K; Suzuki M; Takagi A; Kojima T; Asano H; Nozawa Y; Murate T
    J Neurochem; 2005 Nov; 95(4):940-9. PubMed ID: 16135093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the human EDF-1 minimal promoter: involvement of NFY and Sp1 in the regulation of basal transcription.
    Bolognese F; Pitarque-Martì M; Lo Cicero V; Mantovani R; Maier JA
    Gene; 2006 Jun; 374():87-95. PubMed ID: 16567061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic inflammation: mechanisms regulating IL-5 transcription in human T lymphocytes.
    Wang J; Young IG
    Allergy; 2007 Oct; 62(10):1131-8. PubMed ID: 17845581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.